skin structure infections
Ceftaroline in complicated skin and skin-structure infections
... Abstract: Ceftaroline is an advanced-generation cephalosporin antibiotic recently approved by the US Food and Drug Administration for the treatment of complicated skin and skin-structure ...
13
A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)
... in infections acquired in the community setting in patients who had no identifi able risk factors for the HA ...necrotizing infections and will likely impact the choice of antibiotics ...complicated ...
10
<p>Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy</p>
... bacterial skin and skin-structure infections (ABSSSIs) are de fi ned as bacter- ial infections of the skin with a lesion area of at least 75 cm 2 ...mild infections to ...
10
Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
... bacterial skin and skin structure infections (ABSSSI) are a common disease causing patients to seek treatment through the health care ...these infections are becoming more difficult to ...
10
Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections
... Abstract: Tedizolid phosphate is the first once-daily oxazolidinone approved by the United States Food and Drug Administration for the treatment of acute bacterial skin and skin structure ...
8
Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
... Bacterial Skin and Skin Structure Infections (ABSSSI): integrated safety findings from two phase III ...bacterial skin and skin structure infections: a Phase 3, ...
10
New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
... bacterial skin and skin structure ...excellent skin and soft tissue penetration, bactericidal activity against Gram-positive bacteria including methicillin- resistant Staphylococcus aureus, ...
8
Presence of Genes Encoding the Panton Valentine Leukocidin Exotoxin Is Not the Primary Determinant of Outcome in Patients with Complicated Skin and Skin Structure Infections Due to Methicillin Resistant Staphylococcus aureus: Results of a Multinational Trial
... complicated skin and skin structure infections (cSSSI) caused by methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) is ...
6
Oritavancin for the treatment of acute bacterial skin and skin structure infections: an evidence-based review
... and skin and skin structure infection studies (Figure ...complicated skin and soft tissue ...bacterial skin and skin structure infections (ABSSSIs) caused by ...
9
The Prevalence of Methicillin Resistant Staphylococcus aureus Colonization in Patients with Complicated Skin and Skin Structure Infections after Treatment with Linezolid or Vancomycin
... Background: Complicated skin and skin structure infections (cSSSIs) due to Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), are associated with significant morbidity. ...
9
New developments in the management of severe skin and deep skin structure infections – focus <br /> on tedizolid
... Abstract: Tedizolid, a novel oxazolidinone, is approved for treatment of acute bacterial skin and skin structure infections (ABSSSIs). Tedizolid offers several potential advantages over ...
6
Genotypic Characteristics of Staphylococcus aureus Isolates from a Multinational Trial of Complicated Skin and Skin Structure Infections
... The impact of bacterial genetic characteristics on the outcome of patients with Staphylococcus aureus infections is uncertain. This investigation evaluated potential associations between bacterial genotype and ...
7
Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
... bacterial skin and skin structure infections, such as strains of Staphylo- coccus aureus (including methicillin-resistant ...with skin and skin structure infections ...
18
Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections
... bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP), such as Staphylococcus aureus and Streptococcus ...these infections and its ...
10
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole
... complicated skin and skin structure infections (cSSSIs) have gained more attention recently, most likely due to the recent emergence of community-acquired methicillin resistant Staphylococcus ...
11
Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline
... and skin and skin structure infections are widely varied in ...These infections very often lead to an increase in length of hospital stay, with a resulting increase in costs and ...
12
Role of telavancin in treatment of skin and skin structure infections
... Abstract: Skin and skin structure infections (SSSIs) are a common diagnosis encountered by ambulatory and inpatient practitioners across the ...Keywords: skin and skin ...
7
Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department
... larger infections, previous failure, stable sepsis, etc), the long-acting, intravenous lipoglycopeptides allow the en- tire duration of therapy to be administered as a single dose in the ED, facilitating discharge ...
11
<p>Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials</p>
... S. aureus-, MRSA-, and MSSA-associated ABSSSIs. These fi ndings are supported by the results of in vitro investigations in an included study, 13 which showed that the minimum inhibitory concentration (MIC) of dela fl ox- ...
9
Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections
... a skin source or venipuncture were prioritized over blood cultures drawn from a line, and certain sources of skin cultures with a high risk of con- tamination such as “swabs” were ...tremity ...
9